Laminin α2 muscular dystrophy: Genotype/phenotype studies of 22 patients

Neurology

Volumn 51, Issue 1, 1998, Pages 101-110

  Pegoraro, Elena ^a   Marks, H ^b   Garcia, C A ^c   Crawford, T ^d   Mancias, P ^e   Connolly, A M ^f   Fanin, M ⁿ   Martinello, F ⁿ   Trevisan, C P ⁿ   Angelini, C ⁿ   Stella, A ^a   Scavina, M ^b   Munk, R L ^g   Servidei, S ⁿ   Bonnemann C C ^h   Bertorini, T ⁱ   Acsadi, G ^j   Thompson, C E ^k   Gagnon, D ^l   Hoganson, G ^l   Carver, V ^m   Zimmerman, R A ⁿ   Hoffman, E P ^a   more..

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f WASHINGTON UNIVERSITY   (United States)

^g TOLEDO HOSPITAL   (United States)

^h BOSTON CHILDREN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^j WAYNE STATE UNIVERSITY   (United States)

^k Suite 482   (United States)

^l UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^m UNIVERSITY OF MIAMI   (United States)

ⁿ NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

MEROSIN; LAMININ; LAMININ ALPHA2;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INFANT; MALE; MUSCULAR DYSTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; BIOPSY; CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE DELETION; GENETIC POLYMORPHISM; GENETICS; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRESCHOOL CHILD; SKELETAL MUSCLE;

BASE SEQUENCE; BIOPSY; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE DELETION; GENOTYPE; HUMANS; INFANT; LAMININ; MALE; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUTATION; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0031594947     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.1.101     Document Type: Article

References (47)

1. Tomé FMS, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci Paris 1994;317:351-357.
2. Sewry CA, Philpot J, Mahony D, Wilson LA, Muntoni F, Dubowitz V. Expression of laminin subunits in congenital muscular dystrophy. Neuromusc Disord 1995;5:307-316.
3. Campbell KP, Kahl SD. Association of dystrophin and integral membrane glycoprotein. Nature 1989;338:259-262.
4. Vachon PH, Xu H, Liu L, et al. Integrins (α7β1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J Clin Invest 1997; 100:1870-1881.
5. Arahata K, Ishii H, Hayashi YK. Congenital muscular dystrophies. Curr Opin Neurol 1995;8:385-390.
6. Leyten QH, Gabreëls FJM, Renier WO, ter Laak HJ. Congenital muscular dystrophy: a review of the literature. Child Neurol Neurosurg 1996;98:267-280.
7. Fukuyama Y, Kawazura M, Haruna H. A peculiar form of congenital progressive muscular dystrophy. Pediatr Univ Tokyo 1960;4:5-8.
8. Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations. Brain Dev 1981;13:1-9.
9. Toda T, Segawa M, Nomura Y, et al. Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-q33. Nat Genet 1993;5:283-286.
10. Santavuori P, Leisti J, Kruus S. Muscle, eye and brain disease: a new syndrome. Neuropediatrics 1977;8:553-557.
11. Santavuori P, Somer H, Sainio K, et al. Muscle-eye-brain disease (MEB). Brain Dev 1989;11:147-153.
12. Dobyns WB, Pagon RA, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 1989;32: 195-210.
13. Banker BQ. The congenital muscular dystrophies. In: Engel AG, Franzini-Armstrong C, eds. Myology. Vol. 1. New York: McGraw-Hill, 1994:1275-1289.
14. Philpot J, Sewry C, Pennock J, Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromusc Disord 1995;5:301-305.
15. Vainzof M, Marie SK, Reed UC, et al. Deficiency of merosin (laminin M or alpha 2) in congenital muscular dystrophy associated with cerebral white matter alterations. Neuropediatrics 1995;26:293-297.
16. Reed UC, Marie SK, Vainzof M, et al. Congenital muscular dystrophy with cerebral white matter hypodensity. Correlation of clinical features and merosin deficiency. Brain Dev 1996;18:53-58.
17. Herrman R, Straub V, Meyer K, Kahn T, Wagner M, Voit T. Congenital muscular dystrophy. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 1996;3:1657-1661.
18. Pini A, Merlini L, Tomé FMS, Chevallay M, Gobbi G. Merosin-negative congenital muscular dystrophy, occipital epilepsy with periodic spasms and focal cortical dysplasi. Report of three Italian cases in two families. Brain Dev 199618:316-322.
19. Dubowitz V. Workshop report: 22nd ENMC sponsored workshop on congenital muscular dystrophy. Baarn, The Netherlands, May 1993. Neuromusc Disord 1994;4:75-81.
20. Fardeau M, Tomé FMS, Helbling-Leclerc A, et al. Dystrophie musculaire congenitale avec deficience en merosine: analyse clinique, histopathologique, immunocytochimique et genetique. Rev Neurol (Paris) 1996;152:11-19.
21. Sunada Y, Edgar TS, Lotz BP, Rust RS, Campbell KP. Merosin- negative congenital muscular dystrophy associated with extensive brain abnormalities. Neurology 1995;45:2084-2089.
22. Van der Knaap MS, Smit LME, Barth PG, et al. Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann Neurol 1997;42:50-59.
23. Nissinen M, Helbling-Leclerc A, Zhang X, et al. Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin α2-chain in congenital muscular dystrophy with partial deficiency of the protein. Am J Hum Genet 1996;58:1177-1184.
24. Sewry CA, Naom I, D'Alessandro M, et al. Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragment of the laminin α2 chain. Neuromusc Disord 1997;7:169-175.
25. Allamand V, Sunada Y, Salih MAM, et al. Mild congenital muscular dystrophy in two patients with an internally deleted laminin α2-chain. Hum Mol Genet 1997;6:747-752.
26. De Stefano N, Dotti MT, Villanova M, Scarano G, Federico A. Merosin positive congenital muscular dystrophy with severe involvement of the central nervous system. Brain Dev 1996; 18:323-326.
27. Echenne B, Rivier F, Jellali AJ, Azais M, Mornet D, Pens F. Merosin positive congenital muscular dystrophy with mental deficiency, epilepsy and MRI changes in the cerebral white matter. Neuromusc Disord 1997;7:187-190.
28. Timpl R, Rohde H, Gehron Robey P, et al. Laminin α glycoprotein from basement membranes. J Biol Chem 1979;254: 9933-9937.
29. Ehrig K, Leivo I, Argraves WS, et al. Merosin, a tissue-specific basement membrane protein, is a laminin like protein. Proc Natl Acad Sci USA 1990;87:3264-3268.
30. Voulteenaho R, Nissinen M, Sainio K, et al. Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J Cell Biol 1994;124:381-394.
31. Wewer UM, Engvall E. Merosm/laminin-2 and muscular dystrophy. Neuromusc Disord 1996;6:409-418.
32. Helbling-Leclerc A, Zhang X, Topaloglu H, et al. Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995;11:216-218.
33. Hayashi YK, Koga R, Tsukahara T, et al. Deficiency of laminin α2-chain mRNA in muscle in a patient with merosin-negative congenital muscular dystrophy. Muscle Nerve 1995; 18:1027-1030.
34. Pegoraro E, Mancias P, Swerdlow SH, et al. Laminin α2 (merosin) gene mutations cause congenital muscular dystrophy (CMD). Ann Neurol 1996;40:782-791.
35. Guicheney P, Vignier N, Helbling-Leclerc A, et al. Genetics of laminin α2 chain (or merosin) deficient congenital muscular dystrophy: from identification of mutations to prenatal diagnosis. Neuromusc Disord 1997;7:180-186.
36. Hayashi YK, Ishihara T, Kazuhisa D, Hisae H, Arahata K. A benign allelic form of laminin alpha 2 chain deficient muscular dystrophy. Lancet 1997;349:1147.
37. Duggan DJ, Gorospe JR, Fanin M, et al. Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med 1997;336:618-624.
38. Volt T, Fardeau M, Tomé FM. Prenatal detection of merosin expression in human placenta. Neuropediatrics 1994;25:332-333.
39. Muntoni F, Sewry CA, Wilson L, et al. Prenatal diagnosis of congenital muscular dystrophy. Lancet 1995;345:591.
40. Naom I, Sewry CA, D'Alessandro M, et al. Prenatal diagnosis in merosin-deficient congenital muscular dystrophy. Neuromusc Disord 1997;7:176-179.
41. Pegoraro E, Schimke RN, Garcia C, et al. Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin competent myonuclei. Neurology 1995;45:677-690.
42. Zhang X, Vuolteenaho R, Tryggvason K. Structure of the human laminin α2-chain gene (LAMA2), which is affected in congenital muscular dystrophy. J Biol Chem 1996;271:27664-27669.
43. Mercuri E, Pennock J, Goodwin F, et al. Sequential study of central and peripheral nervous system involvement in an infant with merosin-deficient congenital muscular dystrophy. Neuromusc Disord 1996;6:425-429.
44. Villanova M, Malandrini A, Toti P, et al. Localization of merosin in the normal human brain: implications for congenital muscular dystrophy with merosin deficiency. J Submicroscopic Cytol Path 1996;28:1-4.
45. Cohen J, Johnson AR. Differential effects of laminin and merosin on neurite outgrowth by developing retinal ganglion cells. J Cell Sci 1991;15:1-7.
46. Anton EA, Sandrock AW Jr, Matthew WD. Merosin promotes neurite growth and Schwann cell migration in vitro and nerve regeneration in vive: evidence using an antibody to merosin, ARM-1. Dev Biol 1994;164:133-146.
47. Halfter W. The behavior of optic axons on substrate gradients of retinal basal lamina proteins and merosin. J Neurose 1996; 15:4389-4401.